483
Kite Pharma, Inc.FDA 483 - Kite Pharma, Inc. - November 01, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Kite Pharma, Inc. in Frederick, MD, a finished product drug manufacturer, was cited for failing to report serious and unexpected adverse experiences to the FDA within the required 15 calendar days. The inspection, conducted from October 28 to November 1, 2024, revealed 11 instances where reports were delayed by 17 to 159 days, indicating a significant lapse in regulatory reporting compliance.
Open in Dashboard
ID · 242de29c-a425-4452-8142-20c92fa30e91